News About: Pharm. Industry
The individual growth of major vitamin preparations is noticeable
According to the present sales condition of major vitamin preparations over the past five years, the size of vitamin C market has increased by 29.4%, from 31.2 billion won in 2009 to 40.3 billion in 2013. The size of ...
The 'cash from operations' of top 30 listed-pharmaceutical companies decreased by 55.2%
According to the 'cash from operations' of top 30 listed-pharmaceutical companies in the first quarter settled in December, it was calculated that the CFO decreased by 55.2% on average, from 216.2 billion won in the f...
Domestic and multinational pharmaceutical companies are targeting the hair loss product to be in earnest
On June, according to the related industry, domestic and multinational pharmaceutical companies are targeting the hair loss product to be in earnest.
First of all, hair loss preparation 'Pansidil' which is launched b...
Massive release of generic drugs is scheduled for the second half of year
As patent of weighty originals such as Crestor was expired, lots of generic drugs have been released in the market on the first half of the year, and massive release of generic drugs is also scheduled for the second h...
Ilyang Pharmacuetical is in the process of 'Price Volume agreement' negotiation of 'Noltec'
Ilyang Pharmacuetical is in the process of 'Price Volume agreement' negotiation of 'Noltec' which is no.14 domestic new drug, with National Health Insurance Service. If the maximum of 10% reduction applies on the grou...
Three companies have emerged as candidates for acquiring DreamPharma
Schedule for bidding of DreamPharma is around June 25, with about 10 days remaining. Ahngook Pharmaceutical and Cha Bio group is showing most active step.
However, Albogen has experience of acquring Kunwha Pharmaceut...
Top 30 listed-pharmaceutical companies showed increase in rate of cost to selling price in the first quarter
According to the status analysis of top 30 listed-pharmaceutical companies, it was analyzed that their rate of cost to selling price in the first quarter was an average of 59.5%, which is increased by 0.2% compared to...
Hyundai Pharmaceutical registered insect bites treatment 'Bumooly S' as OTC drug approved by the U.S. FDAHyundai Pharmaceutical registered insect bites treatment 'Bumooly S' as OTC drug approved by the U.S. FDA.
According to Hyundai Pharmaceutical, they completed U.S. FDA register...
|
Kwangdong Pharmaceutical joined the development of erectile dysfunction drug Cialis, with film-type formulation
Kwangdong Pharmaceutical joined the development of erectile dysfunction drug Cialis, with film-type formulation. So three companies which compete with the development of film-type Viagra, changed their target to Ciali...
It was identified that shares of the pharmaceutical industry and is directly proportional to the company's operating profit
It was identified that shares of the pharmaceutical industry and is directly proportional to the company's operating profit in the first quarter of 2014. But sales, net income and did not show a certain correlation.
...
